Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) hit a new 52-week high on Monday . The stock traded as high as $9.2240 and last traded at $9.2240, with a volume of 431 shares changing hands. The stock had previously closed at $8.77.
Aspen Pharmacare Price Performance
The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66. The company has a 50 day moving average price of $8.47 and a 200 day moving average price of $7.59.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over?the?counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
